Seikagaku Corporation Sustainability Profile
Seikagaku Corporation, a leading biopharmaceutical company based in Japan, has established itself as a key player in the field of regenerative medicine and orthopaedics since its founding in 1947. With its headquarters in Tokyo, Seikagaku operates extensively across Asia, Europe, and North America, focusing on the development and manufacturing of innovative products that enhance joint health and tissue regeneration. The company is renowned for its core offerings, including hyaluronic acid-based products, which are uniquely designed to treat osteoarthritis and promote joint function. Seikagaku's commitment to research and development has positioned it as a pioneer in the industry, achieving significant milestones such as the introduction of groundbreaking therapies that have transformed patient care. With a strong market presence and a dedication to advancing medical science, Seikagaku Corporation continues to lead the way in biopharmaceutical innovation.
DitchCarbon Score
How does Seikagaku Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Seikagaku Corporation's score of 40 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Seikagaku Corporation's reported carbon emissions
In 2024, Seikagaku Corporation reported total carbon emissions of approximately 21,775,000 kg CO2e, comprising about 8,345,000 kg CO2e from Scope 1 and about 13,023,000 kg CO2e from Scope 2 emissions. In the previous year, 2023, the company recorded total emissions of about 22,170,000 kg CO2e, with Scope 1 emissions at approximately 8,287,000 kg CO2e and Scope 2 emissions at about 14,433,000 kg CO2e. For the Japanese operations in 2023, Seikagaku disclosed Scope 3 emissions amounting to about 57,262,000 kg CO2e, while the combined Scope 1 and 2 emissions were approximately 22,721,000 kg CO2e. Seikagaku has not set specific reduction targets under the Science Based Targets initiative (SBTi) nor has it made any formal climate pledges. The company’s emissions data is not cascaded from a parent organisation, indicating that all reported figures are directly from Seikagaku Corporation. Overall, Seikagaku Corporation is actively monitoring its carbon footprint, focusing on transparency in emissions reporting, but currently lacks defined reduction initiatives or commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 8,441,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,945,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Seikagaku Corporation's Industry?
How Carbon Intensive is Seikagaku Corporation's Location?
Seikagaku Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Seikagaku Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
